Entheon Biomedical Corp.
ENBI
CNSX
05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 297.60K | 363.90K | 97.40K | 169.40K | 219.30K |
Total Receivables | 8.10K | 4.20K | 3.00K | 3.00K | 3.00K |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 19.40K | 18.60K | 28.10K | 8.60K | 20.00K |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 325.10K | 386.80K | 128.60K | 181.00K | 242.20K |
|
|||||
Total Current Assets | 325.10K | 386.80K | 128.60K | 181.00K | 242.20K |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 3.60K | 3.50K | 3.60K | 3.70K | 3.70K |
Total Assets | 328.80K | 390.20K | 132.10K | 184.80K | 245.80K |
|
|||||
Total Accounts Payable | 9.80K | 42.60K | 26.10K | 13.40K | 29.90K |
Total Accrued Expenses | 1.90K | 1.40K | 2.40K | 1.60K | 600.00 |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | 11.70K | 44.00K | 28.40K | 15.00K | 30.50K |
|
|||||
Total Current Liabilities | 11.70K | 44.00K | 28.40K | 15.00K | 30.50K |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 11.70K | 44.00K | 28.40K | 15.00K | 30.50K |
|
|||||
Common Stock & APIC | 14.98M | 14.28M | 14.35M | 14.87M | 14.70M |
Retained Earnings | -15.19M | -14.60M | -14.94M | -15.96M | -15.74M |
Treasury Stock & Other | 528.60K | 666.50K | 686.50K | 1.27M | 1.25M |
Total Common Equity | 317.10K | 346.30K | 103.70K | 169.80K | 215.40K |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | 317.10K | 346.30K | 103.70K | 169.80K | 215.40K |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | 317.10K | 346.30K | 103.70K | 169.80K | 215.40K |
|